Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkers
Open Access
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 19 (12) , 1593-1605
- https://doi.org/10.1038/modpathol.3800696
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Dynamic Cell Type Specificity of SRC-1 Coactivator in Modulating Uterine Progesterone Receptor Function in MiceMolecular and Cellular Biology, 2005
- Revealing Progesterone's Role in Uterine and Mammary Gland Biology: Insights from the MouseSeminars in Reproductive Medicine, 2005
- Progesterone receptor isoform identification and subcellular localization in endometrial cancerGynecologic Oncology, 2005
- Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcomeLaboratory Investigation, 2004
- Expression of estrogen receptor coregulators in normal and malignant human endometriumGynecologic Oncology, 2004
- Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki‐67 expressionCancer, 2003
- Gene Amplification and Expression of the Steroid Receptor Coactivator SRC3 (AIB1) in Sporadic Breast and Endometrial CarcinomasHormone and Metabolic Research, 2001
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- Expression of EGFR, HER-2/neu, P53, and PCNA in Endometrioid, Serous Papillary, and Clear Cell Endometrial AdenocarcinomasGynecologic Oncology, 1994
- Estrogen and progesterone receptors in endometrial cancer and their prognostic relevanceGynecologic Oncology, 1990